The med-tech industry was ripe with rumors Thursday after a report in the Financial Times, quoting unnamed sources "familiar with the matter," suggested that Abbott Laboratories (Abbott Park, Ill.) was preparing a $25 billion bid for St. Jude Medical (St. Paul, Minn.). Abbott promptly denied the speculation in a company statement. Read More
